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Risk Factors and Outcomes of Postoperative Bowel Ischemia After Abdominal Aortic Aneurysm Repair
Objective: Bowel ischemia (BI) is a rare but serious complication after abdominal aortic aneurysm (AAA) repair. We sought to identify risk factors and outcomes in patients developing BI after open aortic repair (OAR) and endovascular aneurysm repair (EVAR).
Methods: A retrospective analysis was conducted using the Vascular Quality Initiative database (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . Univariate (Student t-test, c
2 ) and multivariate (logistic regression) analyses were used as appropriate. All models were tested using area under the curve and goodness of fit tests.
Results: We evaluated a cohort of 40,467 patients who underwent AAA repair (22.5% OAR and 87.5% EVAR). The overall incidence of postoperative BI was 2.0% (6.2% for OAR vs 0.8% for EVAR; P < .001). A decreasing trend of postoperative BI was noticed from 2003 (4.1%) to 2017 (1.6%; P < .001). Patients with BI were more likely to be female (28% vs 21%) and had a higher number of comorbidities including congestive heart failure (13% vs 11%), chronic obstructive pulmonary disease (38% vs 33%), dialysis (2% vs 1%), and American Society of Anesthesiologists classification >3 (98% vs 94%; all P < .05). In multivariate analysis, OAR was associated with fivefold increased risk for development of BI compared with EVAR (odds ratio [OR], 4.77; 95% confidence interval [CI], 3.56-6.39; P < .001). In patients undergoing OAR, history of smoking (OR, 1.59; 95% CI, 1.01-2.52), congestive heart failure (OR, 1.65; 95% CI, 1.11-2.46), transfusion (OR, 1.09; 95% CI, 1.06-1.11), ruptured aneurysm (OR, 2.68; 95% CI, 1.72-4.17), anterior exposure (OR, 1.92; 95% CI, 1.35-2.74) supraceliac clamping (OR, 1.68; 95% CI, 1.13-2.48), and reimplantation of the inferior mesenteric artery (OR, 1.68; 95% CI, (1.13-2.48) were all significant predictors of BI (all P < .05). In contrast, family history of AAA (OR, 2.47; 95% CI, 1.20-5.09), ruptured aneurysm (OR, 6.93; 95% CI, 3.03-15.82), and any concomitant procedures (OR, 4.19; 95% CI, ) were the only predictors of BI in patients undergoing EVAR. Total length of hospital stay (median days, 18 [interquartile range, 7-32] vs 10 [6-19]) and intensive care unit stay (median days, 11 [interquartile range, 4-22] vs 4.5 [2-10]) were significantly higher in patients who received surgical vs medical management for postoperative BI (both P < .001). Surgical management was also associated with nearly threefold increased risk of 30-day mortality compared with medical management of BI (OR, 2.88; 95% CI, 1.75-4.74; P < .001; Fig) . The 30-day mortality (35% vs 39%) and return to operating room (61% vs 57%) after development of BI were similar between OAR and EVAR (both P > .05).
Conclusions: Using a national vascular-specific database, OAR was associated with fivefold increased risk for development of BI compared with EVAR. Medical management of BI is associated with significant reduction in mortality and should be considered if appropriate. This study highlights some modifiable factors that can reduce BI risk, including transfusion and OAR approach (retroperitoneal). Objective: The effect that ipsilateral tunneled dialysis catheters (TDCs) has on arteriovenous fistula (AVF) maturation is unclear. We sought to define this association by comparing AVF maturation rates in patients with contralateral TDC with those in patients with ipsilateral TDC.
Methods: Review of a prospectively maintained database including all AVF creation procedures between 2009 and 2016 was performed. All patients with a TDC in place at the time of AVF creation were included in this study. Clinical and functional maturation rates were compared in patients with contralateral vs ipsilateral dialysis catheters. Categorical variables were analyzed by a two-tailed Fisher exact test. P values < .05 were considered statistically significant.
Results: There were 187 patients who underwent AVF creation with a TDC in place during the study period. There were 137 patients with a contralateral TDC and 50 with an ipsilateral TDC (Table) . A greater proportion of contralateral patients were first-time dialysis access patients at the time of index AVF creation (67% vs 48%; P ¼ .03). There was no difference in clinical (contralateral, 73%; ipsilateral, 78%; P ¼ .57) and functional (contralateral, 64%; ipsilateral, 74%) maturation rates between the two groups. The rate of TDC removal after functional AVF maturation was also not different (contralateral, 64%; ipsilateral, 72%; P ¼ .30). There was no statistically significant difference in rates of thrombosis <30 days, outflow stenosis, central stenosis, and steal syndrome.
Conclusions: There was no association between TDC sidedness and AVF maturation in our cohort. Ipsilateral TDC was also not associated with early AVF thrombosis. Planning for AVF creation should not be influenced by attempts to avoid an ipsilateral TDC. ACE, angiotensin-converting enzyme; CABG, coronary artery bypass graft; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; ROC, receiver operating characteristic.
